Companies researching Induced pluripotent stem cells (ipscs)

Induced pluripotent stem cells (iPSCs) are lab‑generated stem cells created by reprogramming adult skin or blood cells to an embryonic‑like state, providing an unlimited source of human cells for therapeutic and regenerative medicine research.

1,697

companies

List of companies that research Induced pluripotent stem cells (ipscs)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Security and Investigations

1k

$7.2M

Induced pluripotent stem cells (ipscs)

Country flag

United States

Oil and Gas

250

$70M

Induced pluripotent stem cells (ipscs)

Country flag

United States

Oil and Gas

3.4k

Induced pluripotent stem cells (ipscs)

Country flag

United States

Biotechnology Research

21k

$26B

Induced pluripotent stem cells (ipscs)

Country flag

Luxembourg

Biotechnology Research

61k

$6.9B

Induced pluripotent stem cells (ipscs)

Country flag

France

Research Services

550

Induced pluripotent stem cells (ipscs)

Country flag

United Kingdom

Higher Education

22k

$171M

Induced pluripotent stem cells (ipscs)

Country flag

France

Pharmaceutical Manufacturing

92k

$46B

Induced pluripotent stem cells (ipscs)

Country flag

Japan

Pharmaceutical Manufacturing

12k

Induced pluripotent stem cells (ipscs)

Country flag

United Kingdom

Pharmaceutical Manufacturing

98k

$35B

Induced pluripotent stem cells (ipscs)

Showing top companies out of 1,697 that research Induced pluripotent stem cells (ipscs). Get the full list on TheirStack.

Frequently asked questions